NOVOGEN LIMITED (NRT)

Oncology drug research and development.

On this page you will find:

Company snapshot Delayed share price Company announcements Price history chart Exchange Traded Options

Company details Closing prices Dividends Warrants & Structured Products ASX CFDs

Delayed share price

Prices are delayed by 20 minutes unless stated otherwise in the Conditions. Retrieving any price indicates your acceptance of the Conditions.

Code	Last	% Chg	Bid	Offer	Open	High	Low	Vol
NRT	0.155	0%	0.155	0.160	0.160	0.160	0.155	233,961

NOVOGEN LIMITED details

Please note: ASX relies on third parties to provide the information contained in the company details table, and therefore is unable to assume any responsibility for the accuracy or timeliness of the information.

Issuer Code	NRT
Securities	ASX Code, Security Description ------------------------------ NRT, Ordinary Fully Paid
Official Listing Date	1 September, 1994
GICS Industry Group	Pharmaceuticals, Biotechnology & Life Sciences
Exempt Foreign?	No
Internet Address	http://www.novogen.com
Registered Office Address	Level 1, 1-7 Waterloo Road, NORTH RYDE, NSW, AUSTRALIA, 2113
Head Office Telephone	(02) 9878 0088
Head Office Fax	(02) 9878 0055
Share Registry	COMPUTERSHARE INVESTOR SERVICES PTY LIMITED LEVEL 4, 60 CARRINGTON STREET, SYDNEY, NSW, AUSTRALIA, 2000
Share Registry Telephone	1300 787 272

Directors / Senior Management
Prof. Graham Kelly (Chairman, CEO) Dr Andrew Heaton (Director) Mr Josiah T Austin (Non Exec. Director) Mr Robert Birch (Non Exec. Director) Mr Steven R Coffey (Non Exec. Director) Mr John P O'Connor (Non Exec. Director)

Company Secretary	Mr Andrew Bursill
Principal Activities	Oncology drug research and development.

NOVOGEN LIMITED announcements

How are company announcements published on www.asx.com.au?

Date	Price sens.	Headline	Pages	PDF
23/05/2013		Becoming a substantial holder	5	PDF
10/05/2013		Extension of Share Purchase Plan	1	PDF
07/05/2013		Novogen Oncology Discovery Library and Indications Expand	2	PDF
07/05/2013		Novogen Announces New Executive Appointments	2	PDF
07/05/2013		Change of Registered Office	1	PDF
02/05/2013		Change in substantial holding	5	PDF
01/05/2013		Cleansing Statement	1	PDF
29/04/2013		Appendix 3B	12	PDF
29/04/2013		Amended Final Director's Interest Notice	2	PDF
22/04/2013		Final Director's Interest Notice	2	PDF

> search for past company announcements

Viewing Company Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.

Closing prices

Closing prices are displayed for the last 5 days on which the security traded on ASX within the last 6 months.

Date	Last	% Change	High	Low	Vol *
24 May 2013	0.155	0%	0.160	0.155	233,961
23 May 2013	0.155	-6.06%	0.165	0.155	123,815
22 May 2013	0.165	0%	0.165	0.160	187,689
21 May 2013	0.165	0%	0.165	0.160	608,691
20 May 2013	0.165	0%	0.165	0.165	55,093

* Volume of shares shown represents only those shares traded on ASX.

NOVOGEN LIMITED price history chart

* More charting options are available.

Dividends

How are dividends released on www.asx.com.au?

No dividends have been found for the security NRT. This is likely to be because a dividend has not been announced to the ASX by this company during the specified timeframe or a dividend has been announced but is not yet available on this website.

Exchange Traded Options

No Exchange Traded Options are available over the security NRT

Warrants & Structured Products

No warrants & Structured Products are available over the security NRT

ASX CFDs

No Contracts For Differences are available over the security NRT

MyASX: Login | Sign up